As a dual anti-inflammatory and anti-neoplastic agent, PPS suppress NF-κB signaling and attenuate inflammatory cytokine activity, thereby disrupting the inflammation-cancer axis and suppressing tumor progression. The gene discussed is NFKB1; the disease is cancer.